{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:33Z","timestamp":1762459353525,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","award":["MOA 4500299739"],"award-info":[{"award-number":["MOA 4500299739"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1444-z","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T13:14:45Z","timestamp":1457183685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis"],"prefix":"10.1186","volume":"16","author":[{"given":"Alessandra","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittipos","family":"Visitsunthorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,5]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","volume":"77","author":"L Chitsulo","year":"2000","unstructured":"Chitsulo L, Engels D, Montresor A, Saviolo L. The global status of schistosomiasis and its control. Acta Trop. 2000;77:41\u201351.","journal-title":"Acta Trop"},{"key":"1444_CR2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet"},{"key":"1444_CR3","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our global health decade. PLoS Negl Trop Dis. 2009;3, e485. PMID: 19787054, http:\/\/dx.doi.org\/10.1371\/journal.pntd.0000485 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","volume":"113","author":"CH King","year":"2010","unstructured":"King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010;113:95\u2013104. PMID: 19962954, http:\/\/dx.doi.org\/10.1016\/j.actatropica.2009.11.012 .","journal-title":"Acta Trop"},{"key":"1444_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1742395307084407","volume":"4","author":"CH King","year":"2008","unstructured":"King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4:65\u201379. PMID: 18322031, http:\/\/dx.doi.org\/10.1177\/1742395307084407 .","journal-title":"Chronic Illn"},{"key":"1444_CR6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002106","volume":"7","author":"CC Terer","year":"2013","unstructured":"Terer CC, Bustinduy AL, Magtanong RV, Muhoho N, Mungai PL, Muchiri EM, Kitron CH, King CH, Mutuku FM. Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study. PLoS Negl Trop Dis. 2013;7, e2106. PMID: 23505590, http:\/\/dx.doi.org\/10.1371\/journal.pntd.0002106 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR7","unstructured":"WHO. PCT databank 2013 [updated 2013; cited 8 March2013]. http:\/\/www.who.int\/neglected_diseases\/preventive_chemotherapy\/sch\/en\/index.html ."},{"key":"1444_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.actatropica.2012.04.013","volume":"128","author":"D Rollinson","year":"2013","unstructured":"Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuent\u00e9 LA, Garba A, Mohammed KA, Schur N, Person B, Colley DG, Utzinger J. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128:423\u201340. PMID: 22580511, http:\/\/dx.doi.org\/10.1016\/j.actatropica.2012.04.013 .","journal-title":"Acta Trop"},{"key":"1444_CR9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","volume":"85","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ. Mass drug administration and integrated control for the world\u2019s high-prevalence neglected tropical diseases. Clin Pharmacol Ther. 2009;85:659\u201364. PMID: 19322166, http:\/\/dx.doi.org\/10.1038\/clpt.2009.16 .","journal-title":"Clin Pharmacol Ther"},{"key":"1444_CR10","volume":"5","author":"CH King","year":"2011","unstructured":"King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis. 2011;5, e1321. PMID: 21949893, http:\/\/dx.doi.org\/10.1371\/journal.pntd.0001321 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","volume":"21","author":"NR Bergquist","year":"2005","unstructured":"Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol. 2005;21:112\u20137.","journal-title":"Trends Parasitol"},{"key":"1444_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000244","volume":"2","author":"R Bergquist","year":"2008","unstructured":"Bergquist R, Utzinger J, McManus DP. Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis. 2008;2, e244. PMID: 18575619, http:\/\/dx.doi.org\/10.1371\/journal.pntd.0000244 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0166-6851(87)90088-0","volume":"25","author":"MQ Klinkert","year":"1987","unstructured":"Klinkert MQ, Ruppel A, Beck E. Cloning of diagnostic 31\/32 kilodalton antigens of Schistosoma mansoni. Mol Biochem Parasitol. 1987;25:247\u201355.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0166-6851(89)90025-X","volume":"33","author":"MQ Klinkert","year":"1989","unstructured":"Klinkert MQ, Felleisen R, Link G, Ruppel A, Beck E. Primary structures of Sm31\/32 diagnostic proteins of Schistosoma mansoni and their identification as proteases. Mol Biochem Parasitol. 1989;33:113\u201322.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(97)00098-4","volume":"89","author":"PJ Brindley","year":"1997","unstructured":"Brindley PJ, Kalinna BH, Dalton JP, Day SR, Wong JY, Smythe ML, McManus DP. Proteolytic degradation of host hemoglobin by schistosomes. Mol Biochem Parasitol. 1997;89:1\u20139.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pt.2004.03.004","volume":"20","author":"CR Caffrey","year":"2004","unstructured":"Caffrey CR, McKerrow JH, Salter JP, Sajid M. Blood \u2018n\u2019 guts: an update on schistosome digestive peptidases. Trends Parasitol. 2004;20:241\u20138.","journal-title":"Trends Parasitol"},{"key":"1444_CR17","doi-asserted-by":"crossref","first-page":"39316","DOI":"10.1074\/jbc.M607128200","volume":"281","author":"M Delcroix","year":"2006","unstructured":"Delcroix M, Sajid M, Caffrey CR, Lim KC, Dvor\u00e1k J, Hsieh I, Bahgat M, Dissous C, McKerrow JH. A multienzyme network functions in intestinal protein digestion by platyhelminth parasite. J Biol Chem. 2006;281:39316\u201329.","journal-title":"J Biol Chem"},{"key":"1444_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2007.03.008","volume":"154","author":"M Delcroix","year":"2007","unstructured":"Delcroix M, Medzihradsky K, Caffrey CR, Fetter RD, McKerrow JH. Proteomic analysis of adult S. mansoni gut contents. Mol Biochem Parasitol. 2007;154:95\u20137.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00194-4","volume":"131","author":"M Sajid","year":"2003","unstructured":"Sajid M, McKerrow JH, Hansell E, Mathieu MA, Lucas KD, Hsieh I, Greenbaum D, Bogyo M, Salter JP, Lim KC, Franklin C, Kim JH, Caffrey CR. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol. 2003;131:65\u201375.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molbiopara.2005.06.007","volume":"143","author":"JM Correnti","year":"2005","unstructured":"Correnti JM, Brindley PJ, Pearce EJ. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol. 2005;143:209\u201315.","journal-title":"Mol Biochem Parasitol"},{"key":"1444_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038898","volume":"7","author":"EJ Remarque","year":"2012","unstructured":"Remarque EJ, Roestenberg M, Younis S, Walraven V, van der Werff N, Faber BW, Leroy O, Sauerwein R, Kocken CH, Thomas AW. Humoral immune response to a single allele PfAMA1 vaccine in healthy malaria-na\u00efve adults. PLoS One. 2012;7, e38898. PMID: 22768052, http:\/\/dx.doi.org\/10.1371\/journal.pone.0038898 .","journal-title":"PLoS One"},{"key":"1444_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.12637","volume":"164","author":"B Uttenthal","year":"2014","unstructured":"Uttenthal B, Martinez-Davila I, Ivey A, Craddock C, Chen F, Virchis A, Kottaridis P, Grimwade D, Khwaja A, Stauss H, Morris EC. Wilms\u2019 Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses. Br J Haematol. 2014;164:366\u201375. PMID: 24422723, http:\/\/dx.doi.org\/10.1111\/bjh.12637 .","journal-title":"Br J Haematol"},{"key":"1444_CR23","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(01)00111-6","volume":"19","author":"H Toledo","year":"2001","unstructured":"Toledo H, Baly A, Castro O, Resik S, Lafert\u00e9 J, Rolo F, Navea L, Lobaina L, Cruz O, Miguez J, Serrano T, Sierra B, P\u00e9rez L, Ricardo ME, Dubed M, Lubi\u00e1n AL, Blanco M, Mill\u00e1n JC, Ortega A, Iglesias E, Pent\u00f3n E, Mart\u00edn Z, P\u00e9rez J, D\u00edaz M, Duarte CA. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine. 2001;19:4328\u201336.","journal-title":"Vaccine"},{"key":"1444_CR24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2014.11.016","volume":"33","author":"A Ricciardi","year":"2015","unstructured":"Ricciardi A, Dalton JP, Ndao M. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant. Vaccine. 2015;33:346\u201353. PMID: 25448114, http:\/\/dx.doi.org\/10.1016\/j.vaccine.2014.11.016 .","journal-title":"Vaccine"},{"key":"1444_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.07.019","volume":"304","author":"CM Stack","year":"2005","unstructured":"Stack CM, Dalton JP, Cunneen M, Donnelly S. De-glycosylation of Pichia pastoris-produced Schistosoma mansoni cathepsin B eliminates non-specific reactivity with IgG in normal human serum. J Immunol Methods. 2005;304:151\u20137.","journal-title":"J Immunol Methods"},{"key":"1444_CR26","doi-asserted-by":"crossref","unstructured":"Tucker MS, Karunaratne LB, Lewis FA, Freitas TC, Liang YS. Schistosomiasis. Curr Protoc Immunol. 2013; 103: Unit 19.1. PMID: 24510597; http:\/\/dx.doi.org\/10.1002\/0471142735.im1901s103 .","DOI":"10.1002\/0471142735.im1901s103"},{"key":"1444_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998;221:35\u201341. PMID: 9894896.","journal-title":"J Immunol Methods"},{"key":"1444_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0264-410X(01)00268-7","volume":"20","author":"M Plante","year":"2001","unstructured":"Plante M, Jones T, Allard F, Torossian K, Gauthier J, St-F\u00e9lix N, White GL, Lowell GH, Burt DS. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge. Vaccine. 2001;20:218\u201325.","journal-title":"Vaccine"},{"key":"1444_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","volume":"21","author":"DP McManus","year":"2008","unstructured":"McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 2008;21:225\u201342. PMID: 18202444, http:\/\/dx.doi.org\/10.1128\/CMR.00046-07 .","journal-title":"Clin Microbiol Rev"},{"key":"1444_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085401","volume":"9","author":"R El Ridi","year":"2014","unstructured":"El Ridi R, Tallima H, Selim S, Donnelly S, Cotton S, Gonzales Santana B, et al. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity. PLoS One. 2014;9, e85401. PMID: 24465551, http:\/\/dx.doi.org\/10.1371\/journal.pone.0085401 .","journal-title":"PLoS One"},{"key":"1444_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4269\/ajtmh.1978.27.55","volume":"27","author":"AW Cheever","year":"1978","unstructured":"Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R, Sippel JE. Schistosoma mansoni and S. haematobium infections in Egypt. III. Extrahepatic pathology. Am J Trop Med Hyg. 1978;27:55\u201375.","journal-title":"Am J Trop Med Hyg"},{"key":"1444_CR32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF01600304","volume":"416","author":"K Geboes","year":"1990","unstructured":"Geboes K, El-Dosoky I, El-Wahab A, Abou Almagd K. The immunopathology of Schistosoma mansoni granulomas in human colonic schistosomiasis. Virchows Arch A Pathol Anat Histopathol. 1990;416:527\u201334.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"1444_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gut.31.4.439","volume":"31","author":"AR Mohamed","year":"1990","unstructured":"Mohamed AR, Al Karawi M, Yasawy MI. Schistosomal colonic disease. Gut. 1990;31:439\u201342.","journal-title":"Gut"},{"key":"1444_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-3024.2005.00785.x","volume":"27","author":"LM Ganley-Leal","year":"2005","unstructured":"Ganley-Leal LM, Guarner J, Todd CW, Da\u2019Dara AA, Freeman Jr GL, Boyer AE, Harn DA, Secor WE. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol. 2005;27:341\u20139.","journal-title":"Parasite Immunol"},{"key":"1444_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4269\/ajtmh.1978.27.76","volume":"27","author":"P Minard","year":"1978","unstructured":"Minard P, Dean DA, Jacobson RH, Vannier WE, Murrell KD. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg. 1978;27:76\u201386.","journal-title":"Am J Trop Med Hyg"},{"key":"1444_CR36","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4049\/jimmunol.128.4.1880","volume":"128","author":"A Sher","year":"1982","unstructured":"Sher A, Hieny S, James SL, Asofsky R. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J Immunol. 1982;128:1880\u20134.","journal-title":"J Immunol"},{"key":"1444_CR37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2478(98)00134-5","volume":"65","author":"RA Wilson","year":"1999","unstructured":"Wilson RA, Coulson PS, Mountford AP. Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice? Immunol Lett. 1999;65:117\u201323.","journal-title":"Immunol Lett"},{"key":"1444_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.1979.28.274","volume":"28","author":"JE Byram","year":"1979","unstructured":"Byram JE, Doenhoff MJ, Musallam R, Brink LH, Von Lichtenberg F. Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. II. Pathology. Am J Trop Med Hyg. 1979;28:274\u201385.","journal-title":"Am J Trop Med Hyg"},{"key":"1444_CR39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.1979.28.260","volume":"28","author":"M Doenhoff","year":"1979","unstructured":"Doenhoff M, Musallam R, Bain J, McGregor A. Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis. Am J Trop Med Hyg. 1979;28:260\u20133.","journal-title":"Am J Trop Med Hyg"},{"key":"1444_CR40","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.136.7.2644","volume":"136","author":"BL Mangold","year":"1986","unstructured":"Mangold BL, Dean DA. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol. 1986;136:2644\u20138.","journal-title":"J Immunol"},{"key":"1444_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/pim.12091","volume":"36","author":"TT Melo","year":"2014","unstructured":"Melo TT, Sena IC, Araujo N, Fonseca CT. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization. Parasite Immunol. 2014;36:107\u201311.","journal-title":"Parasite Immunol"},{"key":"1444_CR42","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","volume":"29","author":"W Torben","year":"2011","unstructured":"Torben W, Ahmad G, Zhang W, Siddiqui AA. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine. 2011;29:2262\u201371. PMID: 21277404, http:\/\/dx.doi.org\/10.1016\/j.vaccine.2011.01.040 .","journal-title":"Vaccine"},{"key":"1444_CR43","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/IAI.72.9.5526-5529.2004","volume":"72","author":"TM Kariuki","year":"2004","unstructured":"Kariuki TM, Farah IO, Yole DS, Mwenda JM, Van Dam GJ, Deelder AM, Wilson RA, Coulson PS. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun. 2004;72:5526\u20139.","journal-title":"Infect Immun"},{"key":"1444_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000290","volume":"2","author":"RA Wilson","year":"2008","unstructured":"Wilson RA, Langermans JA, Van Dam GJ, Vervenne RA, Hall SL, Borges WC, et al. Elimination of Schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine? PLoS Negl Trop Dis. 2008;2, e290. PMID: 18820739, http:\/\/dx.doi.org\/10.1371\/journal.pntd.0000290 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2009.05.011","volume":"25","author":"RA Wilson","year":"2009","unstructured":"Wilson RA, Coulson PS. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite\u2019s armour. Trends Parasitol. 2009;25:423\u201331. PMID: 19717340, http:\/\/dx.doi.org\/10.1016\/j.pt.2009.05.011 .","journal-title":"Trends Parasitol"},{"key":"1444_CR46","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1016\/j.vaccine.2012.09.026","volume":"30","author":"W Torben","year":"2012","unstructured":"Torben W, Ahmad G, Zhang W, Nash S, Le L, Karmakar S, Siddiqui AA. Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80 mediated protection against Schistosoma mansoni. Vaccine. 2012;30:6753\u20138. PMID: 23000221, http:\/\/dx.doi.org\/10.1016\/j.vaccine.2012.09.026 .","journal-title":"Vaccine"},{"key":"1444_CR47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","volume":"212","author":"RM Martin","year":"1998","unstructured":"Martin RM, Brady JL, Lee AM. The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice. J Immunol Methods. 1998;212:187\u201392.","journal-title":"J Immunol Methods"},{"key":"1444_CR48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0035-9203(94)90436-7","volume":"88","author":"IR Viana","year":"1994","unstructured":"Viana IR, Sher A, Carvalho OS, Massara CL, Eloi-Santos SM, Pearce EJ, Colley DG, Gazzinelli G, Correa-Oliveira R. Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg. 1994;88:466\u201370.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1444_CR49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","volume":"27","author":"JP Hewitson","year":"2005","unstructured":"Hewitson JP, Hamblin PA, Mountford AP. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol. 2005;27:271\u201380.","journal-title":"Parasite Immunol"},{"key":"1444_CR50","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.163.8.4489","volume":"163","author":"M Street","year":"1999","unstructured":"Street M, Coulson PS, Sadler C, Warnock LJ, McLaughlin D, Bluethmann H, Wilson RA. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol. 1999;163:4489\u201394.","journal-title":"J Immunol"},{"key":"1444_CR51","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","volume":"72","author":"PB Varaldo","year":"2004","unstructured":"Varaldo PB, Leite LC, Dias WO, Miyaji EN, Torres FI, Gebara VC, Arm\u00f4a GR, Campos AS, Matos DC, Winter N, Gicquel B, Vilar MM, McFadden J, Almeida MS, Tendler M, McIntosh D. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun. 2004;72:3336\u201343.","journal-title":"Infect Immun"},{"key":"1444_CR52","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","volume":"105","author":"G Ahmad","year":"2009","unstructured":"Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, et al. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res. 2009;105:1767\u201377. PMID: 19809833, http:\/\/dx.doi.org\/10.1007\/s00436-009-1646-z .","journal-title":"Parasitol Res"},{"key":"1444_CR53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001564","volume":"6","author":"MS Pearson","year":"2012","unstructured":"Pearson MS, Pickering DA, McSorley HJ, Bethony JM, Tribolet L, Dougall AM, Hotez PJ, Loukas A. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis. 2012;6, e1564. http:\/\/dx.doi.org\/10.1371\/journal.pntd.0001564 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1444_CR54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1645\/GE-3186.1","volume":"99","author":"R El Ridi","year":"2013","unstructured":"El Ridi R, Tallima H. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J Parasitol. 2013;99:194\u2013202. PMID: 22985345, http:\/\/dx.doi.org\/10.1645\/GE-3186.1 .","journal-title":"J Parasitol"},{"key":"1444_CR55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2009.07.581","volume":"48","author":"H Tallima","year":"2009","unstructured":"Tallima H, Salah M, Guirguis FR, El Ridi R. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine. 2009;48:239\u201345. PMID: 19717308, http:\/\/dx.doi.org\/10.1016\/j.cyto.2009.07.581 .","journal-title":"Cytokine"},{"key":"1444_CR56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.actatropica.2008.05.004","volume":"108","author":"F Comin","year":"2008","unstructured":"Comin F, Speziali E, Correa-Oliveira R, Faria AM. Aging and immune response in chronic human schistosomiasis. Acta Trop. 2008;108:124\u201330. PMID: 18582841, http:\/\/dx.doi.org\/10.1016\/j.actatropica.2008.05.004 .","journal-title":"Acta Trop"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1444-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:59:55Z","timestamp":1692244795000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/16\/112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,5]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1444-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2016,3,5]]},"article-number":"112"}}